Healthcare / Biotech
Schrödinger
30-Second Executive Brief
Executive Assessment
Schrödinger functions as a regional institution within Healthcare / Biotech, backed by 25% sourcing coverage, with a stable competitive position.
- Maintains 2 mapped relationships across the graph
- 25% sourcing coverage across sourced relationships
- Tracked as regional institution within the Healthcare / Biotech category
Executive Snapshot
- Strategic Role
- Regional Institution
- Sourcing Coverage
- 25%
- Ecosystem Influence
- Moderate
- Strategic Momentum
- Insufficient Data
View Methodology →
Computed live from this entity's own relationships and evidence: how many relationships carry at least one linked citation, weighted with citation recency and source type — independent of Strategic Importance, and not a prediction. Not a hand-typed number; recalculated on every read.
Coverage
- Mapped Relationships
- 2
- Technology Domains
- 2
Strategic Implications
- Central node connecting multiple strategic ecosystems
- Directly influences technology and capital flows
- Material relevance to downstream dependency mapping
Top Opportunities
Top Risks
Critical Dependencies
Computational drug discovery platform company, using physics-based simulation and AI/ML to design new molecules. Schrödinger reported Q2 2026 software annual contract value (ACV) of $29.6 million, up 27%, while executing a strategic business model transition and expanding its partnership with Bristol Myers Squibb to deploy AI for drug discovery.
Sources
Every claim traced to a primary source — evidence, recent activity, and insider filing behavior, all in one place.
Evidence
1 source
- BioSpace — Schrödinger reports Q2 2026 ACV growth of 27%company
Insider Filing Activity
Counts filing frequency only — transaction direction/size wasn't parseable from the sampled filings · sourced from SEC EDGAR · as of Sep 7, 2026
Acquisition & Investment Fit
AI-reasoned, generated only from entities already in InsightNodes's own graph — a hypothetical strategic-fit exercise, not real M&A intelligence or a signal that any deal is planned or in progress.
Relationship Map
The relationships surrounding Schrödinger — ownership, dependencies, regulation, technology and market context. Click any node to make it the new center, 2 levels deep.
Connection type
Click any node to make it the new center. Scroll to zoom, drag to pan.
Schrödinger's Timeline
A sourced, dated history of Schrödinger's key moments — founding to present.
Jan 2026 · Reports Q2 2026 ACV growth of 27%
Schrödinger reported second-quarter 2026 software annual contract value (ACV) of $29.6 million, up 27% year-over-year, amid a broader business model transition.